Cargando…
紫杉醇脂质体单药与紫杉醇脂质体联合奥沙利铂一线治疗老年晚期非小细胞肺癌的随机对照研究
BACKGROUND AND OBJECTIVE: The third generation single-agent drug has been recommended as a first-line chemotherapy for elderly patients with advanced non-small cell lung cancer (NSCLC). The aim of the current radomized trial is to compare the clinical efficacy and toxicities of single-agent paclitax...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000255/ https://www.ncbi.nlm.nih.gov/pubmed/22336235 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.04 |
Ejemplares similares
-
紫杉醇脂质体联合顺铂方案一线治疗晚期非小细胞肺癌的临床随机对照研究
Publicado: (2012) -
紫杉醇脂质体诱导加同期放化疗与序贯放化疗治疗局部晚期非小细胞肺癌的随机对照研究
Publicado: (2011) -
艾迪联合紫杉醇和顺铂治疗晚期非小细胞肺癌的meta分析
Publicado: (2010) -
局部晚期非小细胞肺癌同步放化疗中紫杉醇两种用法的多中心、随机对照研究
Publicado: (2011) -
不同剂量紫杉醇联合卡铂一线治疗晚期非小细胞肺癌的临床研究
Publicado: (2011)